IL1β Induces Mesenchymal Stem Cells Migration and Leucocyte Chemotaxis Through NF-κB
暂无分享,去创建一个
J. Dopazo | F. García-García | I. Cerrada | A. Ruíz-Sauri | J. Montero | P. Sepúlveda | C. Trigueros | M. Rubio | A. Dorronsoro | Elisa Lledó | Rubén Carrero
[1] A. Dietz,et al. Platelet Lysate Consisting of a Natural Repair Proteome Supports Human Mesenchymal Stem Cell Proliferation and Chromosomal Stability , 2011, Cell transplantation.
[2] C. Akdis,et al. Claudin-1 expression in airway smooth muscle exacerbates airway remodeling in asthmatic subjects. , 2011, The Journal of allergy and clinical immunology.
[3] S. Shoelson,et al. Type 2 diabetes as an inflammatory disease , 2011, Nature Reviews Immunology.
[4] S. Ghosh,et al. NF-κB, inflammation, and metabolic disease. , 2011, Cell metabolism.
[5] F. Bootz,et al. Tissue‐resident mesenchymal stem cells attract peripheral blood neutrophils and enhance their inflammatory activity in response to microbial challenge , 2010, Journal of leukocyte biology.
[6] K. Kang,et al. Implication of NOD1 and NOD2 for the Differentiation of Multipotent Mesenchymal Stem Cells Derived from Human Umbilical Cord Blood , 2010, PloS one.
[7] S. Gordon,et al. Alternative activation of macrophages: mechanism and functions. , 2010, Immunity.
[8] J. García-Verdugo,et al. Mesenchymal stem cells provide better results than hematopoietic precursors for the treatment of myocardial infarction. , 2010, Journal of the American College of Cardiology.
[9] Joaquín Dopazo,et al. Babelomics: an integrative platform for the analysis of transcriptomics, proteomics and genomic data with advanced functional profiling , 2010, Nucleic Acids Res..
[10] R. Romieu-Mourez,et al. Cytokine Modulation of TLR Expression and Activation in Mesenchymal Stromal Cells Leads to a Proinflammatory Phenotype1 , 2009, The Journal of Immunology.
[11] N. Frangogiannis,et al. The role of IL-1 in the pathogenesis of heart disease , 2009, Archivum Immunologiae et Therapiae Experimentalis.
[12] Jong Chun Park,et al. TNF-alpha enhances engraftment of mesenchymal stem cells into infarcted myocardium. , 2009, Frontiers in bioscience.
[13] Hong-Jin Kim,et al. Active roles for inhibitory κB kinases α and β in nuclear factor-κB–mediated chemoresistance to doxorubicin , 2008, Molecular Cancer Therapeutics.
[14] Liwen Chen,et al. Paracrine Factors of Mesenchymal Stem Cells Recruit Macrophages and Endothelial Lineage Cells and Enhance Wound Healing , 2008, PloS one.
[15] R. Zhao,et al. Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. , 2008, Cell Stem Cell.
[16] M. Ashraf,et al. Over-expression of CXCR4 on mesenchymal stem cells augments myoangiogenesis in the infarcted myocardium. , 2008, Journal of molecular and cellular cardiology.
[17] F. Montecucco,et al. Human Mesenchymal Stem Cells Inhibit Neutrophil Apoptosis: A Model for Neutrophil Preservation in the Bone Marrow Niche , 2008, Stem cells.
[18] L. Cosmi,et al. Toll‐Like Receptors 3 and 4 Are Expressed by Human Bone Marrow‐Derived Mesenchymal Stem Cells and Can Inhibit Their T‐Cell Modulatory Activity by Impairing Notch Signaling , 2008, Stem cells.
[19] Ruth S. Waterman,et al. Toll‐Like Receptors on Human Mesenchymal Stem Cells Drive Their Migration and Immunomodulating Responses , 2008, Stem cells.
[20] M. O’Banion,et al. The role of interleukin-1 in neuroinflammation and Alzheimer disease: an evolving perspective , 2008, Journal of Neuroinflammation.
[21] Steven J. Greco,et al. Enhancing Effect of IL-1α on Neurogenesis from Adult Human Mesenchymal Stem Cells: Implication for Inflammatory Mediators in Regenerative Medicine1 , 2007, The Journal of Immunology.
[22] N. Gallay,et al. The In Vitro Migration Capacity of Human Bone Marrow Mesenchymal Stem Cells: Comparison of Chemokine and Growth Factor Chemotactic Activities , 2007, Stem cells.
[23] J. Dopazo,et al. FatiGO +: a functional profiling tool for genomic data. Integration of functional annotation, regulatory motifs and interaction data with microarray experiments , 2007, Nucleic Acids Res..
[24] F. Tacke,et al. Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. , 2007, The Journal of clinical investigation.
[25] P. Meltzer,et al. Claudin-1 overexpression in melanoma is regulated by PKC and contributes to melanoma cell motility , 2006, Oncogene.
[26] K. McFarlin,et al. Bone marrow‐derived mesenchymal stromal cells accelerate wound healing in the rat , 2006, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[27] M. Ashraf,et al. Bone Marrow Stem Cells Prevent Left Ventricular Remodeling of Ischemic Heart Through Paracrine Signaling , 2006, Circulation research.
[28] J. Ingwall,et al. Evidence supporting paracrine hypothesis for Akt‐modified mesenchymal stem cell‐mediated cardiac protection and functional improvement , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[29] Joshua M Hare,et al. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[30] M. Hoshino,et al. Bone Marrow Stromal Cells Generate Muscle Cells and Repair Muscle Degeneration , 2005, Science.
[31] M. Pittenger,et al. Human mesenchymal stem cells modulate allogeneic immune cell responses. , 2005, Blood.
[32] H. Okano,et al. Nonhematopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction. , 2004, Blood.
[33] Sankar Ghosh,et al. Signaling to NF-kappaB. , 2004, Genes & development.
[34] P. Iribarren,et al. Chemokines and chemokine receptors: their manifold roles in homeostasis and disease. , 2004, Cellular & molecular immunology.
[35] M. Burnett,et al. Marrow-Derived Stromal Cells Express Genes Encoding a Broad Spectrum of Arteriogenic Cytokines and Promote In Vitro and In Vivo Arteriogenesis Through Paracrine Mechanisms , 2004, Circulation research.
[36] J. Kantelip,et al. Mesenchymal Progenitor Cells Differentiate into an Endothelial Phenotype, Enhance Vascular Density, and Improve Heart Function in a Rat Cellular Cardiomyoplasty Model , 2003, Circulation.
[37] Terence P. Speed,et al. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias , 2003, Bioinform..
[38] C. Carlo-Stella,et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. , 2002, Blood.
[39] Bernhard Moser,et al. Lymphocyte traffic control by chemokines , 2001, Nature Immunology.
[40] R. Class,et al. Marrow stromal cells as a source of progenitor cells for nonhematopoietic tissues in transgenic mice with a phenotype of osteogenesis imperfecta. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[41] Matthias Mann,et al. IKK-1 and IKK-2: Cytokine-Activated IκB Kinases Essential for NF-κB Activation , 1997 .
[42] K. Frei,et al. C-X-C and C-C chemokines are expressed in the cerebrospinal fluid in bacterial meningitis and mediate chemotactic activity on peripheral blood-derived polymorphonuclear and mononuclear cells in vitro. , 1997, Journal of immunology.
[43] D B Young,et al. IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation. , 1997, Science.
[44] T. Maniatis,et al. Transcriptional regulation of endothelial cell adhesion molecules : NF-icB and cytokine-inducible enhancers , 2004 .
[45] R. Alexander,et al. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. , 1993, The Journal of clinical investigation.